Apr 30 2011
Life Science Intelligence (LSI), a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.
The 211-page report includes 140 companies that are:
- At various stages of development
- Aiming to disrupt several medtech markets
- Seeking partnerships/licensing/investors or acquisition
Most of the companies listed in the report include Executive Summaries with the following in-depth content:
- Company Overview (structure, size, year founded, etc.)
- Company Contact Information
- Competitive Landscape
- Technological Advantage
- Stage of Development
- Target Markets
- Financial Summary and Sales Forecasts
- Financing & Partnering Needs
- IP Position & Status
- Management Team
- Exit Strategy & More
LSI's Report on Emerging Medtech Companies in Q1 2011 includes coverage of the innovative companies featured at prominent 2011 investment and partnering meetings such as LSI's Emerging Medical Technologies® online meetings and Medtech Insight/Elsevier's Investment In Innovation (In3)® conferences, as well as new companies identified by LSI's in-house research team during the first quarter of 2011.
"Due to the popularity of this resource among medical technology executives and investors, we are pleased to announce the first quarterly edition of this publication for 2011," said Bernadette Silva, Sr. Director of Business Development & Marketing at LSI.
Companies in the report represent many market segments, including:
- Aesthetics/Dermatology
- Biomaterials
- Biotechnology
- Cardiovascular
- Cell Therapy
- Dental
- Diagnostics
- Drug Delivery
- Endocrine
- Gastroenterology
- Gynecology/Women's Health
- Imaging
- Men's Health
- Neurology
- Oncology
- Ophthalmology
- Orthopedics
- Pain Management
- Patient Monitoring
- Respiratory
- Spine
- Surgery
- Urology
- Vascular
- Wound Management
Source:
Life Science Intelligence (LSI)®